1. Home
  2. List
Reference Patent

Reference - List

  • 16 Hits
  • Search Condition : Filter (MeSH = Bile Duct Neoplasms / drug therapy)
Species Resource Title
Human and Animal Cells RBE(RCB1292) , HuCCT1(RCB1960) SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma.
Human and Animal Cells YSCCC(RCB1549) , HuCCT1(RCB1960) , RBE(RCB1292) , SSP-25(RCB1292) Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
Human and Animal Cells HuH-28(RCB1943) , TGBC1TKB(RCB1129) , TGBC24TKB(RCB1196) Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets.
Human and Animal Cells HuCCT1(RCB1960) , HuH-28(RCB1943) , TFK-1(RCB2537) , TKKK(RCB1907) , TGBC2TKB(RCB1130) , TGBC14TKB(RCB1186) , TGBC18TKB(RCB1169) Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater.
Human and Animal Cells TFK-1(RCB2537) , HuCCT1(RCB1960) Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
Human and Animal Cells HuCCT1(RCB1960) , HuH-28(RCB1943) Anoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation.
Human and Animal Cells MC3T3-G2/PA6(RCB1127) Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas.
Human and Animal Cells TFK-1(RCB2537) UCP2 regulates cholangiocarcinoma cell plasticity via mitochondria-to-AMPK signals.
Human and Animal Cells HuCCT1(RCB1960) , RBE(RCB1292) Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1.
Human and Animal Cells RBE(RCB1292) , YSCCC(RCB1549) Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib.
Human and Animal Cells TFK-1(RCB2537) , HuCCT1(RCB1960) Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts.
Human and Animal Cells HuCCT1(RCB1960) Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) , TFK-1(RCB2537) Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells.
Human and Animal Cells Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
Human and Animal Cells TKKK(RCB1907) , TGBC24TKB(RCB1196) , HuCCT1(RCB1960) Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment.